After calling Rockville, Maryland, home for more than eight years, Big Pharma GSK is planning to move its vaccine and ...
Drug developer GSK is vacating its 635,000-square-foot life sciences lab in Rockville, Maryland, where it was the sole tenant ...
Morgan Stanley initiated coverage of GSK (GSK) with an Equal Weight rating and 1,450 GBp price target The shares trade at an inexpensive ...
The molecule is also being tested in over 100 vaccine clinical trials. Rising QS-21 demand from the pharmaceutical industry ...
15h
The Mail on MSNUlverston: GSK taskforce aims to allocate £2 million by JuneA TASKFORCE will aim to allocate £2 million to a successful project in Ulverston by June as a ‘lasting legacy’ from a pharmaceutical ...
The Seattle Storm signed veteran WNBA star Erica Wheeler to their squad on Wednesday following her two seasons with the Indiana Fever.
Orchard Therapeutics has tasked Robin Kenselaar with accelerating growth of Lenmeldy, the world’s most expensive drug, ...
Morgan Stanley (NYSE:MS) initiated coverage on shares of GlaxoSmithKline (NYSE:GSK:LN) (NYSE: GSK), a $72.5 billion pharmaceutical giant with a 25-year track record of consistent dividend payments, ...
With Chinese firms becoming major players in drug development, the traditional balance of power in global pharmaceuticals is ...
The table below is a review of notable updates that occurred in January 2025 for investigational products in development.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results